3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
58
Phase 2
47
Phase 1
23
Phase 4
10
Phase 1/2
9
Phase NA
6
Phase 2/3
4
Phase EARLY_PHASE1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Interventions
Magnetic Resonance Spectroscopy
23
Metformin
14
pembrolizumab
12
Radiotherapy
12
Biopsy
11
Nivolumab
9
Fluorouracil
9
Cyclophosphamide
9
Temozolomide
7
Radiation
7
Bevacizumab
7
gallium 68 PSMA-11
6
Sirolimus
6
Rituximab
6
Letrozole
6
Etoposide
6
Cisplatin
6
Aspirin
6
olaparib
5
Surveys and Questionnaires
5
Radiosurgery
5
Oxaliplatin
5
Irinotecan
5
Indocyanine Green
5
Granulocyte Colony-Stimulating Factor
5
Fluorodeoxyglucose F18
5
Dexamethasone
5
aldesleukin
4
Surgical Procedures, Operative
4
Proflavine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Completed
×
Daunorubicin
×
Clear all
NCT03568994
2026-01-27
ATACC AML
Baylor College of Medicine
Phase EARLY_PHASE1
Completed
26 enrolled